
Foresight invests £1.9m in Agar Scientific
Foresight Group has invested £1.9m in the management buyout of Agar Scientific from its parent Elektron Technology.
The deal was supported with banking facilities provided by Royal Bank of Scotland.
Following the transaction, Foresight will support Agar in improving its product range and customer engagement through online channels, while expanding internationally.
Company
Agar manufactures scientific laboratory equipment, focusing on electron microscopy products.
The company was founded in 1981 and is headquartered near Stanstead Airport. Agar employs 26 people.
People
Agar Scientific – Darren Likely, Rob Yeo, Paul Light (management).
Foresight Group – Matt Smith (investment director).
Advisers
Equity – Shakespeare Martineau (legal); PKF Cooper Parry (financial due diligence); Neovian Partners (commercial due diligence); Catalysis Advisory (operational due diligence).
Company – HW Corporate Finance (corporate finance).
Latest News
Stonehage Fleming raises USD 130m for largest fund to date, eyes 2024 programme
Multi-family office has seen strong appetite, with investor base growing since 2016 to more than 90 family offices, Meiping Yap told Unquote
Permira to take Ergomed private for GBP 703m
Sponsor deploys Permira VIII to ride new wave of take-privates; Blackstone commits GBP 200m in financing for UK-based CRO
Partners Group to release IMs for Civica sale in mid-September
Sponsor acquired the public software group in July 2017 via the same-year vintage Partners Group Global Value 2017
Change of mind: Sponsors take to de-listing their own assets
EQT and Cinven seen as bellweather for funds to reassess options for listed assets trading underwater